Yes, smoking weed is bad for your lungs. Cannabis smoke contains roughly the same amount of tar as tobacco smoke and up to 20 times more ammonia, a potent irritant that damages airway tissue. Regular use causes chronic bronchitis symptoms, increases airway resistance, and may raise the risk of lung cancer even when tobacco use is accounted for.
That said, the picture is more nuanced than “weed equals cigarettes.” The specific risks depend on how much you smoke, how you inhale, and what form of cannabis you use.
What Cannabis Smoke Contains
People often assume marijuana smoke is somehow “cleaner” than tobacco smoke. Chemical analysis tells a different story. When tested under standard smoking conditions, a marijuana cigarette produced about 37 mg of tar, nearly identical to the 38 mg from a tobacco cigarette. Under heavier puffing conditions, marijuana actually produced more tar: 103 mg versus 80 mg for tobacco.
The biggest difference was ammonia. Marijuana smoke contained roughly 720 micrograms of ammonia per cigarette under standard conditions, compared to just 35.5 micrograms for tobacco. That’s a 20-fold difference. Ammonia is a harsh irritant that inflames the lining of your airways and contributes to that burning sensation in your throat and chest.
Carbon monoxide levels were slightly lower in marijuana smoke than tobacco, but still substantial. Both types of smoke deliver a cocktail of combustion byproducts that damage lung tissue over time.
How Smoking Technique Makes It Worse
The way people smoke weed compounds the problem. Cannabis users typically take larger puffs, inhale more deeply, and hold the smoke in their lungs longer than cigarette smokers. Research from Johns Hopkins found that larger puff volumes produce dose-related increases in both blood THC levels and carbon monoxide absorption. Holding your breath for 10 or 20 seconds after inhaling does raise THC absorption slightly, but it doesn’t actually increase the subjective high. What it does do is give tar, ammonia, and other irritants more time to settle into lung tissue.
In other words, the breath-holding habit many smokers believe “gets them higher” mostly just deposits more harmful particles deeper in the lungs for minimal extra benefit.
Chronic Bronchitis and Daily Symptoms
The most consistent and well-documented effect of regular cannabis smoking is chronic bronchitis. Studies repeatedly show that current cannabis users have significantly higher rates of daily cough, phlegm production, wheezing, and chest sounds compared to nonsmokers. These symptoms mirror what tobacco smokers experience, and when cannabis and tobacco are used together, the effects stack.
The good news is that these symptoms are largely reversible. People who quit smoking marijuana see significant reductions in morning cough, phlegm, and wheezing compared to those who keep smoking. This suggests the airway irritation is ongoing inflammation rather than permanent structural damage, at least for the bronchitis-related symptoms.
What Happens to Lung Function Over Time
Lung function testing in cannabis users produces a somewhat paradoxical result. Unlike tobacco, which steadily reduces how much air you can force out of your lungs, marijuana use is actually associated with slightly higher lung volumes. Cannabis users in population studies showed increased total lung capacity and a higher forced vital capacity (the total amount of air you can exhale) compared to nonsmokers.
This sounds like good news, but it’s not. The increase reflects hyperinflation, meaning the lungs are trapping air because the airways are partially obstructed. Cannabis users also show higher large-airway resistance. So while the raw volume numbers look normal or even elevated, the airways themselves are swollen and narrowed. One study of young adults found that 36% of cannabis-dependent subjects had a reduced ratio of airflow to lung volume, compared to 20% of nonsmokers.
Bullous Lung Disease in Young Smokers
One of the more alarming findings involves a condition sometimes called “bong lung,” where large air-filled sacs called bullae form in the upper portions of the lungs. CT scans of heavy cannabis smokers show bronchial wall thickening, mucus plugging, and paraseptal emphysema with these bullae at the lung tips.
What makes this particularly concerning is the age at which it appears. In tobacco smokers, this type of emphysema typically develops late in life after decades of exposure. In cannabis smokers, it shows up much earlier, sometimes in people in their 20s and 30s. Men appear to be at dramatically higher risk, with one analysis finding an odds ratio of 8.2 for male sex. The condition can develop silently, with no obvious symptoms, until a bulla ruptures and causes a collapsed lung as the first sign of trouble.
Cancer Risk
For years, the relationship between cannabis and lung cancer was considered unclear. Newer data paints a more concerning picture. A large retrospective study using 20 years of medical records from 67 healthcare organizations across the United States, covering nearly 300,000 matched patients, found that people with cannabis use disorder had a 3.87 times higher risk of developing lung or bronchial cancer compared to non-users. The increased risk applied across all tumor types tested: small cell carcinoma, adenocarcinoma, and squamous cell carcinoma all showed roughly 2.5 to 3 times higher risk.
Critically, a sensitivity analysis that removed everyone with documented tobacco use still upheld the association. This suggests the cancer risk is not simply explained by cannabis users also smoking cigarettes.
Fungal Infection Risk
A less obvious danger comes from what’s growing on the cannabis itself. Cannabis plants can harbor fungal pathogens including Aspergillus, the organism behind aspergillosis. For most healthy people, this is a minor concern. But for anyone with a weakened immune system due to cancer treatment, organ transplant, or HIV, inhaling contaminated cannabis can cause serious and sometimes fatal fungal infections. Contaminated cannabis has been implicated in cases of aspergillosis, mucormycosis, and even cryptococcal meningitis.
Vaping Cannabis Is Not Necessarily Safer
Many people switch to vaping cannabis concentrates or oils assuming it’s gentler on the lungs. In 2019, the FDA issued warnings after more than 1,000 reports of severe lung injuries, including deaths, linked to THC-containing vaping products. The majority of tested samples contained THC, and most affected patients had used THC vape products. The primary culprit turned out to be vitamin E acetate, an additive commonly found in black-market THC cartridges, though the FDA’s broader warning applies to any THC vaping product obtained from unregulated sources.
Regulated, lab-tested vape products from licensed dispensaries carry less risk of contamination. But “less risk” is not “no risk,” and the long-term pulmonary effects of inhaling vaporized cannabis oils are still not well understood.
How the Damage Happens at a Cellular Level
Cannabis smoke triggers inflammation in lung tissue through multiple pathways. THC activates a receptor on cell surfaces that sets off a cascade of inflammatory signaling. This leads lung cells to ramp up production of proteins that drive inflammation, including one that recruits immune cells to the area and another that promotes swelling and pain. Lab studies exposing human lung cells to cannabis smoke extract confirmed significant increases in these inflammatory markers at concentrations equivalent to regular smoking.
This chronic, low-grade inflammation is what drives the bronchitis symptoms, airway thickening, and over time, the structural changes seen in heavy users. The inflammation is not just from the combustion byproducts. THC itself, acting through its own receptor, contributes directly to the inflammatory response in lung tissue.